Progressive Care Reports Second Quarter Status Update

MIAMI, July 14, 2017 -- Progressive Care Inc. (OTC PINK:RXMD), through its subsidiaries Smart Medical Alliance, Inc. and PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, the sale of anti-retroviral medications, medication therapy management (MTM), and the supply of prescription medications to long term care facilities, administration and practice management, utilization management, quality assurance, EHR Implementation, billing and coding, health practice risk management, announces $1.7 million in net revenues for June 2017.

PharmCo filled nearly 19,000 prescriptions and realized revenues of over $1.7 million, which represents over a 3% increase over the same month last year. The company is pursuing every avenue of growth, including expanded marketing in Palm Beach County, development of proprietary digital interfaces, and the creation of healthcare compliance and adherence solutions for primary healthcare providers.

The Company is currently undertaking a restructuring of Smart Medical Alliance to adjust to the changes in the healthcare environment. This includes securing new management for the Company and the development of new programs that provide custom solutions for healthcare practitioners.

Progressive Care is continuing a growth and development strategy as a public company through its ongoing relationship with Boustead Securities. The company is actively engaged in communications about prospective merger and acquisition opportunities.

“We continue to push forward on all cylinders,” stated S. Parikh Mars, CEO. “We know we are on the right path as we evolve as healthcare practitioners in the pharmacy space.”

About Progressive Care

Progressive Care, Inc. (OTC PINK:RXMD), through its subsidiary PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals specializing in health practice risk management, compounded medications, the sale of anti-retroviral medications and related medication therapy management, and the supply of prescription medications to long term care facilities.

Cautionary Statement Regarding Forward Looking Statements

Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target”, “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company's actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.

Contact
Armen Karapetyan
Senior Advisor Business Development
[email protected]